Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.
Arthritis Rheum
; 63(5): 1405-15, 2011 May.
Article
in En
| MEDLINE
| ID: mdl-21305523
Full text:
1
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Skin
/
Receptors, Lysophosphatidic Acid
Limits:
Animals
Language:
En
Journal:
Arthritis Rheum
Year:
2011
Type:
Article
Affiliation country:
United States